Literature DB >> 16398660

Central nervous system graft-versus-host disease post allogeneic stem cell transplant.

Jake Shortt, Elspeth Hutton, Mark Faragher, Andrew Spencer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16398660     DOI： 10.1111/j.1365-2141.2005.05864.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  12 in total

1.  Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia.

Authors:  Nimitha R Mathew; Janaki M Vinnakota; Petya Apostolova; Daniel Erny; Shaimaa Hamarsheh; Geoffroy Andrieux; Jung-Seok Kim; Kathrin Hanke; Tobias Goldmann; Louise Chappell-Maor; Nadia El-Khawanky; Gabriele Ihorst; Dominik Schmidt; Justus Duyster; Jürgen Finke; Thomas Blank; Melanie Boerries; Bruce R Blazar; Steffen Jung; Marco Prinz; Robert Zeiser
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

2.  A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation.

Authors:  Gi-June Min; Silvia Park; Sung-Soo Park; Jae-Ho Yoon; Sung-Eun Lee; Byung-Sik Cho; Ki-Seong Eom; Seok Lee; Hee-Je Kim; Chang-Ki Min; Seok-Goo Cho; Dong-Wook Kim; Jong-Wook Lee; Yoo-Jin Kim
Journal:  Int J Hematol       Date:  2019-07-15       Impact factor: 2.490

3.  Successful treatment of meningeal graft-versus-host disease in a haematopoietic stem cell transplant recipient.

Authors:  Victoria Pechey; John Parratt; Linh Vo; William Stevenson
Journal:  Int J Hematol       Date:  2014-11-22       Impact factor: 2.490

Review 4.  Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.

Authors:  Geoffrey D E Cuvelier; Michelle Schoettler; Nataliya P Buxbaum; Iago Pinal-Fernandez; Marc Schmalzing; Jörg H W Distler; Olaf Penack; Bianca D Santomasso; Robert Zeiser; Klemens Angstwurm; Kelli P A MacDonald; W Taylor Kimberly; Naomi Taylor; Ervina Bilic; Bernhard Banas; Maike Buettner-Herold; Namita Sinha; Hildegard T Greinix; Joseph Pidala; Kirk R Schultz; Kirsten M Williams; Yoshihiro Inamoto; Corey Cutler; Linda M Griffith; Stephanie J Lee; Stefanie Sarantopoulos; Steven Z Pavletic; Daniel Wolff
Journal:  Transplant Cell Ther       Date:  2022-05-31

5.  Neurological complications of transplantation: part I: hematopoietic cell transplantation.

Authors:  Amy A Pruitt; Francesc Graus; Myrna R Rosenfeld
Journal:  Neurohospitalist       Date:  2013-01

6.  Case report: Central nervous system involvement of human graft versus host disease: Report of 7 cases and a review of literature.

Authors:  Mathilde Ruggiu; Wendy Cuccuini; Karima Mokhtari; Véronique Meignin; Régis Peffault de Latour; Marie Robin; Flore Sicre de Fontbrune; Aliénor Xhaard; Gérard Socié; David Michonneau
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

7.  Chronic Graft-versus-host Disease Presenting with Multiple Punctate Intracranial Lesions on Contrast-enhanced Magnetic Resonance Imaging.

Authors:  Makoto Terada; Kiyotaka Nakamagoe; Naoshi Obara; Shinichi Ogawa; Noriaki Sakamoto; Taiki Sato; Seitaro Nohara; Shigeru Chiba; Akira Tamaoka
Journal:  Intern Med       Date:  2017-02-01       Impact factor: 1.271

8.  Intractable myoclonic seizures in an allogeneic stem cell transplant recipient: A rare case of myoclonic epilepsy.

Authors:  Anna Robuccio; Paddy Ssentongo; Michael D Sather; David F Claxton; Frank G Gilliam
Journal:  Epilepsy Behav Case Rep       Date:  2015-08-08

9.  A confusing case of multiple sclerosis and central nervous system graft versus host disease.

Authors:  Byung-Nam Yoon; Choong Kun Ha; Kwang-Woo Lee; Sung-Hye Park; Jung-Joon Sung
Journal:  Korean J Intern Med       Date:  2016-02-03       Impact factor: 2.884

Review 10.  Acute Graft-Versus-Host Disease, Infections, Vascular Events and Drug Toxicities Affecting the Central Nervous System.

Authors:  Janaki Manoja Vinnakota; Robert Zeiser
Journal:  Front Immunol       Date:  2021-10-06       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.